These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 38031778)

  • 21. Treatment-resistant schizophrenia: challenges and implications for clinical practice.
    Šagud M
    Psychiatr Danub; 2015 Sep; 27(3):319-26. PubMed ID: 26400145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of antipsychotic drugs: focus on therapeutic and adverse effects.
    Werner FM; Coveñas R
    Expert Opin Drug Saf; 2014 Aug; 13(8):1031-42. PubMed ID: 24975932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of clozapine on psychiatric symptoms, cognition, and functional outcome in schizophrenia.
    Manschreck TC; Redmond DA; Candela SF; Maher BA
    J Neuropsychiatry Clin Neurosci; 1999; 11(4):481-9. PubMed ID: 10570762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?
    Green AI; Zimmet SV; Strous RD; Schildkraut JJ
    Harv Rev Psychiatry; 1999; 6(6):287-96. PubMed ID: 10370435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting Microglial Immunoproteasome: A Novel Approach in Neuroinflammatory-Related Disorders.
    Malek N; Gladysz R; Stelmach N; Drag M
    ACS Chem Neurosci; 2024 Jul; 15(14):2532-2544. PubMed ID: 38970802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression.
    Fornari Laurindo L; Aparecido Dias J; Cressoni Araújo A; Torres Pomini K; Machado Galhardi C; Rucco Penteado Detregiachi C; Santos de Argollo Haber L; Donizeti Roque D; Dib Bechara M; Vialogo Marques de Castro M; de Souza Bastos Mazuqueli Pereira E; José Tofano R; Jasmin Santos German Borgo I; Maria Barbalho S
    Front Immunol; 2023; 14():1305933. PubMed ID: 38259497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Leponex, 10 years after -- a clinical review].
    Llorca PM; Pere JJ
    Encephale; 2004; 30(5):474-91. PubMed ID: 15627052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-Inflammatory properties of antipsychotics via microglia modulations: are antipsychotics a 'fire extinguisher' in the brain of schizophrenia?
    Kato TA; Monji A; Mizoguchi Y; Hashioka S; Horikawa H; Seki Y; Kasai M; Utsumi H; Kanba S
    Mini Rev Med Chem; 2011 Jun; 11(7):565-74. PubMed ID: 21699487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of clozapine on cognitive functioning in schizophrenia.
    McGurk SR
    J Clin Psychiatry; 1999; 60 Suppl 12():24-9. PubMed ID: 10372607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo immunomodulatory effects of clozapine in schizophrenia.
    Maes M; Bosmans E; Kenis G; De Jong R; Smith RS; Meltzer HY
    Schizophr Res; 1997 Aug; 26(2-3):221-5. PubMed ID: 9323354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clozapine: in prevention of suicide in patients with schizophrenia or schizoaffective disorder.
    Wagstaff A; Perry C
    CNS Drugs; 2003; 17(4):273-80; discussion 281-3. PubMed ID: 12665398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine.
    Arranz MJ; Collier DA; Munro J; Sham P; Kirov G; Sodhi M; Roberts G; Price J; Kerwin RW
    Neurosci Lett; 1996 Oct; 217(2-3):177-8. PubMed ID: 8916101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clozapine and negative symptoms. An open study.
    Llorca PM; Lancon C; Farisse J; Scotto JC
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Apr; 24(3):373-84. PubMed ID: 10836486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of schizophrenia in children and adolescents. The role of clozapine.
    Remschmidt H; Fleischhaker C; Hennighausen K; Schulz E
    Paediatr Drugs; 2000; 2(4):253-62. PubMed ID: 10946414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol.
    Gomes FV; Llorente R; Del Bel EA; Viveros MP; López-Gallardo M; Guimarães FS
    Schizophr Res; 2015 May; 164(1-3):155-63. PubMed ID: 25680767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clozapine versus typical neuroleptic medication for schizophrenia.
    Essali A; Al-Haj Haasan N; Li C; Rathbone J
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD000059. PubMed ID: 19160174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of clozapine and typical antipsychotic drugs on plasma 5-HT turnover and impulsivity in patients with schizophrenia: a cross-sectional study.
    Dursun SM; Szemis A; Andrews H; Whitaker P; Reveley MA
    J Psychiatry Neurosci; 2000 Sep; 25(4):347-52. PubMed ID: 11022399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of the antipsychotics haloperidol and clozapine on G protein measures in mononuclear leukocytes of patients with schizophrenia.
    Avissar S; Roitman G; Schreiber G
    Cell Mol Neurobiol; 2001 Dec; 21(6):799-811. PubMed ID: 12043849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [How do clozapine and co. work? Pharmacologic mechanisms of atypical neuroleptics].
    Müller WE
    Pharm Unserer Zeit; 2002; 31(6):537-45. PubMed ID: 12481511
    [No Abstract]   [Full Text] [Related]  

  • 40. Classics in chemical neuroscience: clozapine.
    Wenthur CJ; Lindsley CW
    ACS Chem Neurosci; 2013 Jul; 4(7):1018-25. PubMed ID: 24047509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.